These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9337436)

  • 1. Removal of vancomycin during plasmapheresis.
    McClellan SD; Whitaker CH; Friedberg RC
    Ann Pharmacother; 1997 Oct; 31(10):1132-6. PubMed ID: 9337436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin clearance in high-volume venovenous hemofiltration.
    Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
    Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
    del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
    Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin sequestration during cardiopulmonary bypass surgery.
    Krivoy N; Yanovsky B; Kophit A; Zaher A; Bar-El Y; Adler Z; Gaitini L; Milo S
    J Infect; 2002 Aug; 45(2):90-5. PubMed ID: 12217710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters.
    Murphy JE; Gillespie DE; Bateman CV
    Am J Health Syst Pharm; 2006 Dec; 63(23):2365-70. PubMed ID: 17106010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
    Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
    Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin removal during a plasma exchange transfusion.
    Foral MA; Heineman SM
    Ann Pharmacother; 2001 Nov; 35(11):1400-2. PubMed ID: 11724092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardio-pulmonary bypass on vancomycin plasma concentration decay.
    Miglioli PA; Merlo F; Grabocka E; Padrini R
    Pharmacol Res; 1998 Oct; 38(4):275-8. PubMed ID: 9774490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.